VEGF-C: An indicator of lymph node metastasis for patients that underwent esophagectomy

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2027-2031

  Wang, Xiaohang ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Esophageal cancer; Lymphatic metastasis; Surgical procedures; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN C;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; ESOPHAGUS RESECTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84872071761     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12294     Document Type: Article

References (29)

1. Chen G, Wang Z, Liu X Y, et al.: Recurrence pattern of squamous cell carcinoma in the middle thoracic esophagus after modified Ivor-Lewis esophagectomy. World J Surg 2007; 31:1107-1114.
2. Dresner SM, Griffin SM: Pattern of recurrence following radical of esophagectomy with two-field lymphadenectomy. British J Surg 2000; 87:1426-1433.
3. Zhang MY, Wang Z, Liu XY, et al.: The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II. A middle-third thoracic esophageal cancer. Chinese J Surg 2008; 46:1048-1050.
4. Saharinen P, Tammela T, Karkkainen MJ, et al.: Lymphatic vasculature: development, molecular regulationand role in tumor metastasis and inflammation. Trends Immunol 2004; 25:387-395.
5. Wu QW, She HQ, Liang J, et al.: Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. BMC Cancer 2012; 12:47.
6. Wang Z, Liu XY, Liu FY, et al.: A study of correlation between early postoperative relapse with lymph node micrometastasis in patients with NO esophageal cancer. Chinese J Surg 2004; 42:68-71.
7. Tachibana M, Kinugasa S, Yoshimura H, et al.: Extended esophagectomy with 3-field lymph node dissection for esophageal cancer. Arch Surg 2003; 138(12):1383-1390.
8. th ed. Philadelphia: LWW.com. 2000:1905.
9. Law S, Wong J: Two-field dissection is enough for esophageal cancer. Dis Esophagus 2001; 14(2):98-103.
10. Song L, Liu Y, Wang Z, et al.: Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma. Hepato-gastroenterol 2012; 59(115):738-741.
11. Wang Z, Liu XY, Liu FY, et al.: Ivor-Lewis esophagectomy for treatment of esophageal cancer and Cox regression analysis of prognostic factors. Tumor 2004; 24(3):286-289.
12. Wang Z, Liu XY, Chen G, et al.: The evaluation for therapeutic efficacy of the modified Ivor-Lewis surgery on squamous cell cancer in the middle-third thoracic esophagus. Chinese J Clin Oncol 2006; 33:1012-1015.
13. Joukov V, Pajusola K, Kaipainen A, et al.: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15:290-298.
14. Kaipainen A, Korhonen J, Mustonen T, et al.: Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci 1995; 92:3566-3570.
15. Jeltsch M, Kaipainen A, Joukov V, et al.: Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276:1423-1425.
16. Oh SJ, Jeltsch MM, Birkenhäger R, et al.: VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 1997; 188(1):96-109.
17. Oh SJ, Jeltsch MM, Birkenhäger R, et al.: Signaling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO J 2001; 20:1223-1231.
18. Achen MG, McColl BK, Stacker SA: Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005; 7:121-127.
19. Von Marschall Z, Scholz A, Stacker SA, et al.: Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. Int J Oncol 2005; 27:669-679.
20. Kopfstein L, Veikkola T, Djonov VG, et al.: Distinct roles of vascular endothelial growth factor-d in lymphangiogenesis and metastasis. Am J Pathol 2007; 170:1348-1361.
21. Yonemura Y, Endo Y, Fujita H, et al.: Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999; 5:1823-1829.
22. Tsurusaki T, Kanda S, Sakai H, et al.: Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999; 80:309-313.
23. Kajita T, Ohta Y, Kimura K, et al.: The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer. Br J Cancer 2001; 85:255-260.
24. Liu H, Xiao J, Yang Y, et al.: COX-2 expression is correlated with VEGF-C, lymphangiogenesis and lymph node metastasis in human cervical cancer. Microvasc Res 2011; 82:131-140.
25. Wu QW, She HQ, Liang J, et al.: Expression and clinical significance of extracellular matrix protein 1 and vascular endothelial growth factor-C in lymphatic metastasis of human breast cancer. BMC Cancer 2012; 12:47.
26. Kozlowski M, Naumnik W, Niklinski J, et al.: Vascular endothelial growth factor C and D expression correlates with lymph node metastasis and poor prognosis in patients with resected esophageal cancer. Neoplasma 2011; 58:311-319.
27. Tanaka T, Ishiguro H, Kuwabara Y, et al.: Vascular endothelial growth factor C (VEGF-C) in esophageal cancer correlates with lymph node metastasis and poor patient prognosis. J Exp Clin Cancer Res 2010; 29:83.
28. Liu P, Chen W, Zhu H, et al.: Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas. Jpn J Clin Oncol 2009; 39:644-650.
29. Okazawa T, Yoshida T, Shirai Y, et al.: Expression of vascular endothelial growth factor C is a prognostic indicator in esophageal cancer. Hepato-gastroenterol 2008; 55:1503-1508.